Administration of angiotensin II, but not catecholamines, induces accumulation of lipids in the rat heart

European Journal of Pharmacology

Volumn 604, Issue 1-3, 2009, Pages 87-92

  Hongo, Makiko ^a   Ishizaka, Nobukazu ^a   Furuta, Kyoko ^a   Yahagi, Naoya ^a   Saito, Kan ^a   Sakurai, Ryota ^a   Matsuzaki, Gen ^a   Koike, Kazuhiko ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiotensin II; Gene expression; Lipid accumulation; Lipotoxicity

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CATECHOLAMINE; FATTY ACID SYNTHASE; HYDRALAZINE; LIPID; LOSARTAN; MESSENGER RNA; NORADRENALIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SUPEROXIDE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; HEART; LIPID METABOLISM; LIPID STORAGE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; UPREGULATION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; GENE EXPRESSION; HYPERTENSION; LIPID METABOLISM; LIPIDS; MALE; MYOCARDIUM; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDES;

EID: 58949093401     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.12.006     Document Type: Article

References (27)

1. Affourtit C., Crichton P.G., Parker N., and Brand M.D. Novel uncoupling proteins. Novartis Found. Symp. 287 (2007) 70-80 Discussion 80-91
2. Aizawa T., Ishizaka N., Taguchi J., Nagai R., Mori I., Tang S.S., Ingelfinger J.R., and Ohno M. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 35 (2000) 800-806
3. Arsenijevic D., Onuma H., Pecqueur C., Raimbault S., Manning B.S., Miroux B., Couplan E., Alves-Guerra M.C., Goubern M., Surwit R., Bouillaud F., Richard D., Collins S., and Ricquier D. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat. Genet. 26 (2000) 435-439
4. Cheng L., Ding G., Qin Q., Huang Y., Lewis W., He N., Evans R.M., Schneider M.D., Brako F.A., Xiao Y., Chen Y.E., and Yang Q. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat. Med. 10 (2004) 1245-1250
5. Chiu H.C., Kovacs A., Blanton R.M., Han X., Courtois M., Weinheimer C.J., Yamada K.A., Brunet S., Xu H., Nerbonne J.M., Welch M.J., Fettig N.M., Sharp T.L., Sambandam N., Olson K.M., Ory D.S., and Schaffer J.E. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ. Res. 96 (2005) 225-233
6. Finck B.N., Han X., Courtois M., Aimond F., Nerbonne J.M., Kovacs A., Gross R.W., and Kelly D.P. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1226-1231
7. Fujita K., Maeda N., Sonoda M., Ohashi K., Hibuse T., Nishizawa H., Nishida M., Hiuge A., Kurata A., Kihara S., Shimomura I., and Funahashi T. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 863-870
8. Furuta E., Pai S.K., Zhan R., Bandyopadhyay S., Watabe M., Mo Y.Y., Hirota S., Hosobe S., Tsukada T., Miura K., Kamada S., Saito K., Iiizumi M., Liu W., Ericsson J., and Watabe K. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res. 68 (2008) 1003-1011
9. Gharavi N.M., Baker N.A., Mouillesseaux K.P., Yeung W., Honda H.M., Hsieh X., Yeh M., Smart E.J., and Berliner J.A. Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids. Circ. Res. 98 (2006) 768-776
10. Horiuchi M., Yoshida H., Kobayashi K., Kuriwaki K., Yoshimine K., Tomomura M., Koizumi T., Nikaido H., Hayakawa J., Kuwajima M., et al. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett. 326 (1993) 267-271
11. Ichihara S., Obata K., Yamada Y., Nagata K., Noda A., Ichihara G., Yamada A., Kato T., Izawa H., Murohara T., and Yokota M. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors. J. Mol. Cell. Cardiol. 41 (2006) 318-329
12. Ishizaka N., de Leon H., Laursen J.B., Fukui T., Wilcox J.N., De Keulenaer G., Griendling K.K., and Alexander R.W. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation 96 (1997) 1923-1929
13. Ishizaka N., Aizawa T., Yamazaki I., Usui S., Mori I., Kurokawa K., Tang S.S., Ingelfinger J.R., Ohno M., and Nagai R. Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration. Lab. Invest. 82 (2002) 87-96
14. Ishizaka N., Matsuzaki G., Saito K., Noiri E., Mori I., and Nagai R. Expression and localization of PDGF-B, PDGF-D, and PDGF receptor in the kidney of angiotensin II-infused rat. Lab. Invest. 86 (2006) 1285-1292
15. Jones B.H., Standridge M.K., and Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 138 (1997) 1512-1519
16. Kim S., Dugail I., Standridge M., Claycombe K., Chun J., and Moustaid-Moussa N. Angiotensin II-responsive element is the insulin-responsive element in the adipocyte fatty acid synthase gene: role of adipocyte determination and differentiation factor 1/sterol-regulatory-element-binding protein 1c. Biochem. J. 357 (2001) 899-904
17. Lee Y., Naseem R.H., Duplomb L., Park B.H., Garry D.J., Richardson J.A., Schaffer J.E., and Unger R.H. Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13624-13629
18. McGavock J.M., Lingvay I., Zib I., Tillery T., Salas N., Unger R., Levine B.D., Raskin P., Victor R.G., and Szczepaniak L.S. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116 (2007) 1170-1175
19. Saito K., Ishizaka N., Aizawa T., Sata M., Iso O.N., Noiri E., Ohno M., and Nagai R. Role of aberrant iron homeostasis in the upregulation of transforming growth factor-beta1 in the kidney of angiotensin II-induced hypertensive rats. Hypertens. Res. 27 (2004) 599-607
20. Saito K., Ishizaka N., Hara M., Matsuzaki G., Sata M., Mori I., Ohno M., and Nagai R. Lipid accumulation and transforming growth factor-beta upregulation in the kidneys of rats administered angiotensin II. Hypertension 46 (2005) 1180-1185
21. Schaffer J.E. Lipotoxicity: when tissues overeat. Curr. Opin. Lipidol. 14 (2003) 281-287
22. Sharma S., Adrogue J.V., Golfman L., Uray I., Lemm J., Youker K., Noon G.P., Frazier O.H., and Taegtmeyer H. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. Faseb. J. 18 (2004) 1692-1700
23. Tian R., Musi N., D'Agostino J., Hirshman M.F., and Goodyear L.J. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 104 (2001) 1664-1669
24. Uchiyama S., Shimizu T., and Shirasawa T. CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice. J. Biol. Chem. 281 (2006) 31713-31719
25. Unger R.H. Lipotoxic diseases. Annu. Rev. Med. 53 (2002) 319-336
26. Vikramadithyan R.K., Hirata K., Yagyu H., Hu Y., Augustus A., Homma S., and Goldberg I.J. Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy. J. Pharmacol. Exp. Ther. 313 (2005) 586-593
27. Zhou Y.T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., Orci L., and Unger R.H. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1784-1789